Brca1-deficient pancreatic ductal adenocarcinoma cells are hyper-sensitive to DNA-damaging agents

被引:0
作者
Hirsch, S. [1 ,2 ]
Shakya, R. [2 ]
Szabolcs, M. [2 ]
Hartmann, J-T [1 ]
Ludwig, T. [2 ]
机构
[1] Univ Klinikum Schleswig Holstein, Kiel, Germany
[2] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, New York, NY USA
来源
ONKOLOGIE | 2011年 / 34卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:57 / 57
页数:1
相关论文
共 50 条
[31]   A chemical genetic screen reveals novel ATR/ATM pathway inhibitors that sensitize p53-deficient cells to DNA-damaging agents [J].
Kawasumi, M. ;
Sloan, H. ;
Bradner, J. ;
Nghiem, P. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 :S26-S26
[32]   Nuclear deformability increases PARPi sensitivity in BRCA1-deficient cells by increasing microtubule-dependent DNA break mobility [J].
Faustini, Elena ;
dello Stritto, Angela ;
Panza, Andrea ;
Doksani, Ylli ;
Lottersberger, Francisca .
NATURE COMMUNICATIONS, 2025, 16 (01)
[33]   Use of DNA-Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients [J].
Walker, Logan C. ;
Thompson, Bryony A. ;
Waddell, Nic ;
Grimmond, Sean M. ;
Spurdle, Amanda B. .
PLOS GENETICS, 2010, 6 (02)
[34]   A Rare Cell-penetrating Anti-DNA Antibody Inhibits DNA Repair, Sensitizes Tumors To DNA-damaging Therapy, and is Synthetically Lethal to BRCA2-deficient Cancer Cells [J].
Hansen, J. E. ;
Chan, G. ;
Liu, Y. ;
Gera, J. ;
Sweasy, J. B. ;
Sung, P. ;
Rockwell, S. ;
Nishimura, R. N. ;
Weisbart, R. H. ;
Glazer, P. M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03) :S163-S163
[35]   Polymerase theta inhibition synergizes with anti-PD-1 immunotherapy in BRCA2-deficient pancreatic ductal adenocarcinoma. [J].
Patterson-Fortin, Jeffrey ;
Jadhav, Heta ;
Pantelidou, Constantia ;
Phan, Tin ;
Grochala, Carter ;
Hao, Jie ;
Wang, Junning ;
Andrews, Elizabeth A. ;
Guerriero, Jennifer L. ;
Wolpin, Brian M. ;
Stanger, Ben Z. ;
Aguirre, Andrew A. ;
Cleary, James M. ;
D'Andrea, Alan A. ;
Shapiro, Geoffrey I. .
CANCER RESEARCH, 2022, 82 (22) :117-118
[36]   Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents [J].
Hirai, Hiroshi ;
Iwasawa, Yoshikazu ;
Okada, Megumu ;
Arai, Tsuyoshi ;
Nishibata, Toshihide ;
Kobayashi, Makiko ;
Kimura, Toshifumi ;
Kaneko, Naoki ;
Ohtani, Junko ;
Yamanaka, Kazunori ;
Itadani, Hiraku ;
Takahashi-Suzuki, Ikuko ;
Fukasawa, Kazuhiro ;
Oki, Hiroko ;
Nambu, Tadahiro ;
Jiang, Jian ;
Sakai, Takumi ;
Arakawa, Hiroharu ;
Sakamoto, Toshihiro ;
Sagara, Takeshi ;
Yoshizumi, Takashi ;
Mizuarai, Shinji ;
Kotani, Hidehito .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) :2992-3000
[37]   P53 AND FAS/APO-1 INDUCTION IN HEPATOMA-CELLS IN RESPONSE TO TREATMENT WITH DNA-DAMAGING AGENTS [J].
MUELLER, M ;
AFINIAWANI, EM ;
KRAMMER, P ;
VOLKMANN, M ;
STREMMEL, W ;
GALLE, PR .
HEPATOLOGY, 1995, 22 (04) :200-200
[38]   Cdk1 depletion disrupts BRCA1 function and selectively sensitizes cancer cells to DNA damaging agents [J].
Johnson, Neil ;
Cai, Dongpo ;
Kennedy, Richard ;
Pathania, Shailja ;
Parvin, Jeffrey ;
D'Andrea, Alan ;
Shapiro, Geoffrey .
CANCER RESEARCH, 2009, 69
[39]   Brca1-deficient ovarian cancer cells are sensitized to the DNA-strand-breaking nucleoside analog sapacitabine that synergizes with PARP inhibition [J].
Liu, Xiaojun ;
Jiang, Yingjun ;
Nowak, Billie ;
Tikhomirova, Dariya ;
Plunkett, William .
CANCER RESEARCH, 2015, 75
[40]   Functional HRD by RAD51 identi fi es BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents [J].
Casartelli, C. ;
Tommasi, C. ;
Lazzarin, A. ;
Coriano, M. ;
Tornali, C. ;
Serra, O. ;
Campanini, N. ;
Gutierrez-Enriquez, S. ;
Sikokis, A. ;
Zanoni, D. ;
Minari, R. ;
Bortesi, B. ;
Michiara, M. ;
Boggiani, D. ;
Uliana, V. ;
Llop-Guevara, A. ;
Serra, V. ;
Musolino, A. ;
Pellegrino, B. .
ESMO OPEN, 2024, 9 (07)